Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bell

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|January 20, 2016
Characterizing and quantifying the effects of breast cancer therapy using mathematical modelingWalter M Gregory, Christopher J Twelves, Richard Bell, et al.
JAMA Surgery|May 1, 2018
Association of Expectations of Training With Attrition in General Surgery ResidentsJonathan S Abelson, Julie A Sosa, Matthew M Symer, et al.
Brachytherapy|August 21, 2010
Prostatic length predicts functional outcomes after iodine-125 prostate brachytherapyRaj P Pal, Jaimin R Bhatt, Masood A Khan, et al.
The Journal of Surgical Research|November 23, 2018
Impact of Medical School Experience on Attrition From General Surgery ResidencyMatthew M Symer, Jonathan S Abelson, Natalie Z Wong, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Langerhans cells regulate immunity in adulthood by regulating postnatal dermal lymphatic developmentJi Hyun Sim, Richard Bell, Zhonghui Feng, et al.
Cancers|November 27, 2025
The Preoperative Prognosticators of Surgical Margins (R0 vs. R1) in Pelvic Exenteration-A 14-Year Retrospective Study from a Tertiary Referral CentreSabina Ioana Nistor, Roman Mykula, Richard Bell, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 6, 2010
Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practiceGelareh Farshid, Jane E Armes, Richard Bell, et al.
Alcoholism, Clinical and Experimental Research|January 31, 2006
Structural and functional modifications in glutamateric synapses following prolonged ethanol exposureL Judson Chandler, Ezekiel Carpenter-Hyland, Adam W Hendricson, et al.
Asia-Pacific Journal of Clinical Oncology|May 7, 2014
Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectivesRichard De Boer, Jane Beith, Jacquie Chirgwin, et al.
The Lancet. Oncology|October 18, 2017
Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trialRobert Coleman, Andrew Hall, Joan Albanell, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|January 20, 2016
Characterizing and quantifying the effects of breast cancer therapy using mathematical modelingWalter M Gregory, Christopher J Twelves, Richard Bell, et al.
JAMA Surgery|May 1, 2018
Association of Expectations of Training With Attrition in General Surgery ResidentsJonathan S Abelson, Julie A Sosa, Matthew M Symer, et al.
Brachytherapy|August 21, 2010
Prostatic length predicts functional outcomes after iodine-125 prostate brachytherapyRaj P Pal, Jaimin R Bhatt, Masood A Khan, et al.
The Journal of Surgical Research|November 23, 2018
Impact of Medical School Experience on Attrition From General Surgery ResidencyMatthew M Symer, Jonathan S Abelson, Natalie Z Wong, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Langerhans cells regulate immunity in adulthood by regulating postnatal dermal lymphatic developmentJi Hyun Sim, Richard Bell, Zhonghui Feng, et al.
Cancers|November 27, 2025
The Preoperative Prognosticators of Surgical Margins (R0 vs. R1) in Pelvic Exenteration-A 14-Year Retrospective Study from a Tertiary Referral CentreSabina Ioana Nistor, Roman Mykula, Richard Bell, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 6, 2010
Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practiceGelareh Farshid, Jane E Armes, Richard Bell, et al.
Alcoholism, Clinical and Experimental Research|January 31, 2006
Structural and functional modifications in glutamateric synapses following prolonged ethanol exposureL Judson Chandler, Ezekiel Carpenter-Hyland, Adam W Hendricson, et al.
Asia-Pacific Journal of Clinical Oncology|May 7, 2014
Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectivesRichard De Boer, Jane Beith, Jacquie Chirgwin, et al.
The Lancet. Oncology|October 18, 2017
Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trialRobert Coleman, Andrew Hall, Joan Albanell, et al.
Pageof 10